Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.

Hsieh JJ, Hayward SD.

Science. 1995 Apr 28;268(5210):560-3.

PMID:
7725102
2.

Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.

Henkel T, Ling PD, Hayward SD, Peterson MG.

Science. 1994 Jul 1;265(5168):92-5.

PMID:
8016657
3.
5.

The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.

Zimber-Strobl U, Kremmer E, Grässer F, Marschall G, Laux G, Bornkamm GW.

EMBO J. 1993 Jan;12(1):167-75.

7.
8.
9.
10.

Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.

Strobl LJ, Höfelmayr H, Stein C, Marschall G, Brielmeier M, Laux G, Bornkamm GW, Zimber-Strobl U.

Immunobiology. 1997 Dec;198(1-3):299-306. Review.

PMID:
9442401
11.
12.

Epstein-Barr virus nuclear antigen 2 induces FcRH5 expression through CBF1.

Mohan J, Dement-Brown J, Maier S, Ise T, Kempkes B, Tolnay M.

Blood. 2006 Jun 1;107(11):4433-9. Epub 2006 Jan 26.

13.

Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.

Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S.

J Virol. 1993 May;67(5):2853-61.

15.

A role for SKIP in EBNA2 activation of CBF1-repressed promoters.

Zhou S, Fujimuro M, Hsieh JJ, Chen L, Hayward SD.

J Virol. 2000 Feb;74(4):1939-47.

16.

Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.

Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, Tomkinson B, Kieff E.

J Virol. 1995 May;69(5):3108-16.

17.

Functional replacement of the intracellular region of the Notch1 receptor by Epstein-Barr virus nuclear antigen 2.

Sakai T, Taniguchi Y, Tamura K, Minoguchi S, Fukuhara T, Strobl LJ, Zimber-Strobl U, Bornkamm GW, Honjo T.

J Virol. 1998 Jul;72(7):6034-9.

18.

Supplemental Content

Support Center